Skip to main content

. 1978 Mar;5(3):275–277. doi: 10.1111/j.1365-2125.1978.tb01641.x

Chronic pulmonary disease and antipyrine disposition.

S N Agnihotri, R A Clark, S Cooper, A O Iyun, G T Tucker

PMCID: PMC1429263 PMID: 656277

275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Andreasen P. B., Vesell E. S. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration. Clin Pharmacol Ther. 1974 Dec;16(6):1059–1065. doi: 10.1002/cpt19741661059. [DOI] [PubMed] [Google Scholar]
Branch R. A., Herbert C. M., Read A. E. Determinants of serum antipyrine half-lives in patients with liver disease. Gut. 1973 Jul;14(7):569–573. doi: 10.1136/gut.14.7.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
Branch R. A., Shand D. G., Wilkinson G. R., Nies A. S. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest. 1974 Apr;53(4):1101–1107. doi: 10.1172/JCI107647. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cumming J. F. The effect of arterial oxygen tension on antipyrine half-time in plasma. Clin Pharmacol Ther. 1976 Apr;19(4):498–471. [PubMed] [Google Scholar]
Prescott L. F., Adjepon-Yamoah K. K., Roberts E. Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol. 1973 Mar;25(3):205–207. doi: 10.1111/j.2042-7158.1973.tb10625.x. [DOI] [PubMed] [Google Scholar]
Roberts C. J., Jackson L., Halliwell M., Branch R. A. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol. 1976 Oct;3(5):907–913. doi: 10.1111/j.1365-2125.1976.tb00646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Roth R. A., Jr, Rubin R. J. Role of blood flow in carbon monoxide- and hypoxic hypoxia-induced alterations in hexobarbital metabolism in rats. Drug Metab Dispos. 1976 Sep-Oct;4(5):460–467. [PubMed] [Google Scholar]
Sotaniemi E., Arvela P., Huhti E., Koivisto O. Half-life of tolbutamide in patients with chronic respiratory failure. Eur J Clin Pharmacol. 1971 Dec;4(1):29–31. doi: 10.1007/BF00568895. [DOI] [PubMed] [Google Scholar]
Sotaniemi E., Isoaho R., Huhti E., Huikko M., Koivisto O. Increased clearance of ethanol from the blood of asthmatic patients. Ann Allergy. 1972 May;30(5):254–257. [PubMed] [Google Scholar]
Vestal R. E., Norris A. H., Tobin J. D., Cohen B. H., Shock N. W., Andres R. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther. 1975 Oct;18(4):425–432. doi: 10.1002/cpt1975184425. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES